Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges

On the size of the active site in proteases. I. Papain

Schechter, I., & Berger, A. (1967) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(67)80055-x · Cited by 5,256

How Matrix Metalloproteinases Regulate Cell Behavior

Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959

Structure and function of matrix metalloproteinases and TIMPs

Nagase, H., Visse, R., & MURPHY, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.002 · Cited by 3,507

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076

Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761

Matrix metalloproteinases and the regulation of tissue remodelling

Page-McCaw, A., Ewald, A. J., & Werb, Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2125 · Cited by 2,630

Amyloid Precursor Protein Processing and Alzheimer's Disease

O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061

Tissue inhibitors of metalloproteinases: evolution, structure and function

Brew, K., Dinakarpandian, D., & Nagase, H. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00279-4 · Cited by 1,932

Matrix metalloproteinases as modulators of inflammation and innate immunity

Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929

Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction

Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0297-y · Cited by 1,728

MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover

Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Gehron Robey, P., Poole, A. R., Pidoux, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80064-1 · Cited by 1,298

Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., Holtzman, D. M., Betsholtz, C., Armulik, A., Sallstrom, J., et al. (2012) · Nature · doi:10.1038/nature11087 · Cited by 1,293

Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy

Overall, C. M., & Kleifeld, O. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1821 · Cited by 1,239

Extracellular matrix remodelling: the role of matrix metalloproteinases

Stamenkovic, I. (2003) · The Journal of Pathology · doi:10.1002/path.1400 · Cited by 1,174

Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors

Whittaker, M. A., Floyd, C. D., Brown, P. D. N., & Gearing, A. J. H. (1999) · Chemical Reviews · doi:10.1021/cr9804543 · Cited by 995

APP processing in Alzheimer’s disease.

Zhang, Y.-W., Thompson, R., Zhang, H., & Xu, H. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-3 · Cited by 983

S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death

Gu, Z., Kaul, M., Yan, B., Kridel, S. J., Cui, J., Strongin, A., Smith, J. W., Liddington, R. C., & Lipton, S. A. (2002) · Science · doi:10.1126/science.1073634 · Cited by 950

Blood–brain barrier breakdown as a therapeutic target in traumatic brain injury

Shlosberg, D., Benifla, M., Kaufer, D., & Friedman, A. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.74 · Cited by 897

Matrix metalloproteinases in neuroinflammation

Rosenberg, G. A. (2002) · Glia · doi:10.1002/glia.10108 · Cited by 868

Is there new hope for therapeutic matrix metalloproteinase inhibition?

Vandenbroucke, R. E., & Libert, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4390 · Cited by 856

Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases

Gabathuler, R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 829

Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc‐binding environments (HEXXHXXGXXH and Met‐turn) and topologies and should be grouped into a common family, the ‘metzincins’

Bode, W., Gomis‐Rüth, F. X., & Stöckler, W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80312-i · Cited by 762

Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers

Rempe, R. G., Hartz, A. M., & Bauer, B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655551 · Cited by 721

Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms

Golub, L. M., Lee, H. M., RYAN, M. E., Giannobile, W. V., Payne, J. B., & Sorsa, T. A. (1998) · Advances in Dental Research · doi:10.1177/08959374980120010501 · Cited by 690

Alzheimer’s disease: A matter of blood–brain barrier dysfunction?

Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672

Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I

Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y., & Tryggvason, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060037197 · Cited by 666

Not just amyloid: physiological functions of the amyloid precursor protein family

Müller, U. C., Deller, T., & Korte, M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.29 · Cited by 634

Matrix metalloproteinases and their multiple roles in neurodegenerative diseases

Rosenberg, G. A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70016-x · Cited by 594

Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics

Rodrı́guez, D., Morrison, C., & Overall, C. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.09.015 · Cited by 568

Matrix metalloproteinases: Fold and function of their catalytic domains

Tallant, C., Marrero, A., & Gomis‐Rüth, F. X. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.04.003 · Cited by 474

The Many Substrates of Presenilin/γ-Secretase

Haapasalo, A., & Kovacs, D. M. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101065 · Cited by 458

Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and Remodeling

Chen, Q., Jin, M., Yang, F., Zhu, J., Xiao, Q., & Zhang, L. (2013) · Mediators of Inflammation · doi:10.1155/2013/928315 · Cited by 456

η-Secretase processing of APP inhibits neuronal activity in the hippocampus

Willem, M., Tahirovic, S., Busche, M. A., Ovsepian, S. V., Chafai, M., Kootar, S., Hornburg, D., Evans, L. D. B., Moore, S., Daria, A., et al. (2015) · Nature · doi:10.1038/nature14864 · Cited by 398

Matrix Metalloproteinases Expressed by Astrocytes Mediate Extracellular Amyloid-β Peptide Catabolism

Yin, K.-J., Cirrito, J. R., Yan, P., Hu, X., Xiao, Q., Pan, X., Bateman, R., Song, H., Hsu, F.-F., Turk, J., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2085-06.2006 · Cited by 381

Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ

Yan, P., Hu, X., Song, H., Yin, K., Bateman, R. J., Cirrito, J. R., Xiao, Q., Hsu, F. F., Turk, J. W., Xu, J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602440200 · Cited by 380

Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis

Devy, L., Huang, L., Naa, L., Yanamandra, N., Pieters, H., Frans, N., Chang, E. Q., Tao, Q., Vanhove, M., Lejeune, A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3255 · Cited by 361

Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1–40).

Backstrom, J. R., Lim, G. P., Cullen, M. J., & Tökés, Z. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-24-07910.1996 · Cited by 331

Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease

Holmes, C. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.6.788 · Cited by 330

To bind zinc or not to bind zinc: An examination of innovative approaches to improved metalloproteinase inhibition

Jacobsen, J. A., Jourden, J. L. M., Miller, M. T., & Cohen, S. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.08.006 · Cited by 327

The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma

Fields, G. B. (2019) · Cells · doi:10.3390/cells8090984 · Cited by 304

MMP-9 Inhibition: a Therapeutic Strategy in Ischemic Stroke

Chaturvedi, M., & Kaczmarek, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8538-z · Cited by 296

Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity

White, A. R., Du, T., Laughton, K. M., Volitakis, I., Sharples, R. A., Xilinas, M. E., Hoke, D. E., Holsinger, R. M. D., Evin, G., Cherny, R. A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602487200 · Cited by 284

Insights into the physiological function of the β‐amyloid precursor protein: beyond Alzheimer's disease

Dawkins, E., & Small, D. H. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12675 · Cited by 279

Identification and Characterization of the Fifth Membrane-type Matrix Metalloproteinase MT5-MMP

Pei, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8925 · Cited by 268

A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity

Marchant, D., Bellac, C. L., Moraes, T. J., Wadsworth, S. J., Dufour, A., Butler, G. S., Bilawchuk, L. M., Hendry, R. G., Robertson, A. G., Cheung, C., et al. (2014) · Nature Medicine · doi:10.1038/nm.3508 · Cited by 268

Synaptic circuit remodelling by matrix metalloproteinases in health and disease

Huntley, G. W. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3320 · Cited by 267

β‐Amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?

Carson, J. A., & Turner, A. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00855.x · Cited by 264

Matrix Metalloproteinase-9 Facilitates Remyelination in Part by Processing the Inhibitory NG2 Proteoglycan

Larsen, P. H., Wells, J. E. A., Stallcup, W. B., Opdenakker, G., & Yong, V. W. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11127.2003 · Cited by 264

Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain

Dzwonek, J., Rylski, M., & Kaczmarek, L. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.070 · Cited by 259

Blood-brain barrier transport machineries and targeted therapy of brain diseases

Barar, J., Rafi, M. A., Pourseif, M. M., & Omidi, Y. (2016) · Bioimpacts · doi:10.15171/bi.2016.30 · Cited by 259

Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors.

Llano, E., Pendás, A. M., Freije, J. M. P., Nakano, A., Knäuper, V., Murphy, G., & López-Otín, C. (1999) · PubMed · Cited by 258

Matrix Metalloproteinases as Valid Clinical Target

Fingleton, B. (2006) · Current Pharmaceutical Design · doi:10.2174/138161207779313551 · Cited by 247

MMP-1 drives immunopathology in human tuberculosis and transgenic mice

Elkington, P. T., Shiomi, T., Breen, R. A. M., Nuttall, R. K., Ugarte‐Gil, C., Walker, N. F., Saraiva, L., Pedersen, B., Mauri, F. A., Lipman, M. C. I., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45666 · Cited by 243

Matrix Metalloproteinase-2 Facilitates Wound Healing Events That Promote Functional Recovery after Spinal Cord Injury

Hsu, J.-Y. C., McKeon, R. J., Goussev, S., Werb, Z., Lee, J.-U., Trivedi, A. A., & Noble‐Haeusslein, L. J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1993-06.2006 · Cited by 238

Metalloproteinases in atherosclerosis

Johnson, J. L. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.09.007 · Cited by 227

MMPs in the central nervous system: Where the good guys go bad

AGRAWAL, S., LAU, L., & Yong, V. W. (2007) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2007.06.003 · Cited by 226

Updated Biological Roles for Matrix Metalloproteinases and New “Intracellular” Substrates Revealed by Degradomics

Butler, G. S., & Overall, C. M. (2009) · Biochemistry · doi:10.1021/bi901656f · Cited by 225

Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Rivera, S., Khrestchatisky, M., Kaczmarek, L., Rosenberg, G. A., & Jaworski, D. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3467-10.2010 · Cited by 223

Recent Developments in the Design of Specific Matrix Metalloproteinase Inhibitors aided by Structural and Computational Studies

Rao, B. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382115 · Cited by 221

Recent advances in MMP inhibitor design

Fisher, J. F., & Mobashery, S. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7894-9 · Cited by 215

Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects

Johnson, A. R., Pavlovsky, A. G., Ortwine, D. F., Prior, F., Man, C.-F., Bornemeier, D. A., Banotai, C. A., Mueller, W. T., McConnell, P., Yan, C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703286200 · Cited by 212

The Design, Structure, and Clinical Update of Small Molecular Weight Matrix Metalloproteinase Inhibitors

Skiles, J. W., Gonnella, N. C., & Jeng, A. Y. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364018 · Cited by 209

MMPs in learning and memory and neuropsychiatric disorders

Beroun, A., Mitra, S., Michaluk, P., Pijet, B., Stefaniuk, M., & Kaczmarek, L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03180-8 · Cited by 207

Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases

Brkic, M., Balusu, S., Libert, C., & Vandenbroucke, R. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/620581 · Cited by 205

Crystal structures of MMPs in complex with physiological and pharmacological inhibitors

Maskos, K. (2004) · Biochimie · doi:10.1016/j.biochi.2004.11.019 · Cited by 205

The β-Secretase-Derived C-Terminal Fragment of βAPP, C99, But Not Aβ, Is a Key Contributor to Early Intraneuronal Lesions in Triple-Transgenic Mouse Hippocampus

Lauritzen, I., Pardossi-Piquard, R., Bauer, C., Brigham, E., Abraham, J.-D., Ranaldi, S., Fraser, P., St-George-Hyslop, P., Le Thuc, O., Espin, V., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2775-12.2012 · Cited by 201

The role of matrix metalloproteinases in glioma invasion

Nakada, M. (2003) · Frontiers in Bioscience · doi:10.2741/1016 · Cited by 201

MMP Inhibition and Downregulation by Bisphosphonates

Teronen, O. P., Heikkilä, P., Konttinen, Y. T., Laitinen, M., Salo, T. A., Hanemaaijer, R., TERONEN, A., Maisi, P. S., & Sorsa, T. A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07702.x · Cited by 200

Potent and Selective Mechanism-Based Inhibition of Gelatinases

Brown, S., Bernardo, M. M., Li, Z., Kotra, L. P., Tanaka, Y., Fridman, R. A., & Mobashery, S. (2000) · Journal of the American Chemical Society · doi:10.1021/ja001461n · Cited by 198

Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases

Brkić, M., Balusu, S., Wonterghem, E. V., Gorlé, N., Benilova, I., Kremer, A., Hove, I. V., Moons, L., Strooper, B. D., Kanazir, S., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0006-15.2015 · Cited by 192

The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes

Hannocks, M., Zhang, X., Gerwien, H., Chashchina, A. A., Burmeister, M., Korpos, É., Song, J., & Sorokin, L. M. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.11.007 · Cited by 190

Next generation matrix metalloproteinase inhibitors — Novel strategies bring new prospects

Levin, M., Udi, Y., Solomonov, I., & Sagi, I. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.06.009 · Cited by 186

A Greek Tragedy: The Growing Complexity of Alzheimer Amyloid Precursor Protein Proteolysis

Andrew, R. J., Kellett, K. A. B., Thinakaran, G., & Hooper, N. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.746032 · Cited by 186

Macrophage Elastase (Matrix Metalloproteinase-12) Suppresses Growth of Lung Metastases

Houghton, A. M., Grisolano, J. L., Baumann, M. L., Kobayashi, D. K., Hautamaki, R. D., Nehring, L. C., Cornelius, L. A., & Shapiro, S. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-0297 · Cited by 183

Gene expression changes by amyloid β peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes

Walker, D. G., Link, J., Lue, L., Dalsing-Hernandez, J. E., & Boyes, B. E. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705377 · Cited by 183

Macrophage elastase kills bacteria within murine macrophages

Houghton, A. M., Hartzell, W. O., Robbins, C. S., Gomis‐Rüth, F. X., & Shapiro, S. D. (2009) · Nature · doi:10.1038/nature08181 · Cited by 180

Matrix Metalloproteinase Inhibitors

Dormán, G., Cseh, S., Hajdú, I., Barna, L., Konya, D., Kupai, K., Kovács, L., & Ferdinándy, P. (2010) · Drugs · doi:10.2165/11318390-000000000-00000 · Cited by 180

Neuronal activity‐dependent increase of net matrix metalloproteinase activity is associated with MMP‐9 neurotoxicity after kainate

Jourquin, J., Tremblay, E., Décanis, N., Charton, G., Hanessian, S., Chollet, A., Le Diguardher, T., Khrestchatisky, M., & Rivera, S. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02876.x · Cited by 178

A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor

Miyazaki, K., Hasegawa, M. L., Funahashi, K., & Umeda, M. (1993) · Nature · doi:10.1038/362839a0 · Cited by 175

The past, present and future perspectives of matrix metalloproteinase inhibitors

Li, K., Tay, F. R., & Yiu, C. K. Y. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107465 · Cited by 172

A Selective Matrix Metalloproteinase-12 Inhibitor Retards Atherosclerotic Plaque Development in Apolipoprotein E–Knockout Mice

Johnson, J. L., Devel, L., Czarny, B., George, S. J., Jackson, C. L., Rogakos, V., Beau, F., Yiotakis, A., Newby, A. C., & Dive, V. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.219147 · Cited by 171

Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation

Scannevin, R. H., Alexander, R., Mezzasalma, T. M., Burke, S. L., Singer, M. M., Huo, C., Zhang, Y., Maguire, D., Spurlino, J. C., Deckman, I. C., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.806075 · Cited by 171

Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment

Bruno, M. A., Mufson, E. J., Wuu, J., & Cuello, A. C. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181c22569 · Cited by 163

Development of Selective Inhibitors and Substrate of Matrix Metalloproteinase-12

Devel, L., Rogakos, V., David, A., Makaritis, A., Beau, F., Cuniasse, P., Yiotakis, A., & Dive, V. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600222200 · Cited by 160

Structural and functional bases for allosteric control of MMP activities: Can it pave the path for selective inhibition?

Sela-Passwell, N., Rosenblum, G., Shoham, T., & Sagi, I. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.04.010 · Cited by 159

Inactivation of Capicua drives cancer metastasis

Okimoto, R. A., Breitenbuecher, F., Olivas, V. R., Wu, W., Gini, B., Hofree, M., Asthana, S., Hrustanovic, G., Flanagan, J., Tulpule, A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3728 · Cited by 159

Clinical Potential of Minocycline for Neurodegenerative Disorders

BLUM, D., CHTARTO, A., TENENBAUM, L., BROTCHI, J., & LEVIVIER, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.012 · Cited by 157

Cerebrovascular pathology during the progression of experimental Alzheimer's disease

Giannoni, P., Arango-Lievano, M., das Neves, I., Rousset, M.-C., Baranger, K., Rivera, S., Jeanneteau, F. D., Claeysen, S., & Marchi, N. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.001 · Cited by 152

Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP).

Sato, H., Takino, T., Kinoshita, T., Imai, K., Okada, Y., Stetler Stevenson, W. G., & Seiki, M. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00389-4 · Cited by 150

Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor Growth

Remacle, A. G., Golubkov, V. S., Shiryaev, S. A., Dahl, R. S., Stebbins, J. L., Chernov, A. V., Cheltsov, A. V., Pellecchia, M., & Strongin, A. Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4149 · Cited by 146

Myelin Formation during Development of the CNS Is Delayed in Matrix Metalloproteinase-9 and -12 Null Mice

Larsen, P. H., DaSilva, A. G., Conant, K. E., & Yong, V. W. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1880-05.2006 · Cited by 143

Zinc‐Binding Groups Modulate Selective Inhibition of MMPs

Agrawal, A., Romero‐Perez, D., Jacobsen, J. A., Villarreal, F. J., & Cohen, S. M. (2008) · ChemMedChem · doi:10.1002/cmdc.200700290 · Cited by 143

Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy

Ager, E. I., Kozin, S. V., Kirkpatrick, N. D., Seano, G., Kodack, D. P., Askoxylakis, V., Huang, Y., Goel, S., Snuderl, M., Muzikansky, A., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv017 · Cited by 138

Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9

Hernandez-Guillamon, M., Mawhirt, S., Blais, S., Montaner, J., Neubert, T. A., Rostagno, A., & Ghiso, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.610931 · Cited by 137

Proteolysis of Aβ Peptide from Alzheimer Disease Brain by Gelatinase A

Roher, A. E., Kasunic, T. C., Woods, A. S., Cotter, R. J., Ball, M. J., & Fridman, R. A. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2872 · Cited by 135

MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease

Baranger, K., Marchalant, Y., Bonnet, A. E., Crouzin, N., Carrete, A., Paumier, J.-M., Py, N. A., Bernard, A., Bauer, C., Charrat, E., et al. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1992-1 · Cited by 133

Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain.

Asahina, M., Yoshiyama, Y., & Hattori, T. (2001) · PubMed · Cited by 130

Identifying Chelators for Metalloprotein Inhibitors Using a Fragment-Based Approach

Jacobsen, J. A., Fullagar, J. L., Miller, M. T., & Cohen, S. M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101266s · Cited by 129

Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer’s disease brain

Yoshiyama, Y., Asahina, M., & Hattori, T. (2000) · Acta Neuropathologica · doi:10.1007/pl00007428 · Cited by 128

Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia.

Rivera, S., Ogier, C., Jourquin, J., Timsit, S., Szklarczyk, A. W., Miller, K., Gearing, A. J. H., Kaczmarek, L., & Khrestchatisky, M. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01838.x · Cited by 128

Small-Molecule Anticancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9

Dufour, A., Sampson, N. S., Li, J., Kuscu, C., Rizzo, R. C., DeLeon, J. L., Zhi, J., Jaber, N. L., Liu, E. V., Zucker, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4552 · Cited by 128

Matrix metalloproteinase‐2 (MMP‐2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins

Ogier, C., Bernard, A., Chollet-Gravey, A.-M., Diguardher, T. L., Hanessian, S., Charton, G., Khrestchatisky, M., & Rivera, S. (2006) · Glia · doi:10.1002/glia.20349 · Cited by 124

Role of Matrix Metalloproteinase 3-mediated α-Synuclein Cleavage in Dopaminergic Cell Death

Choi, D.-H., Kim, Y.-J., Kim, Y.-G., Joh, T. H., Beal, M. F., & Kim, Y.-S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.222430 · Cited by 123

Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain

Gasche, Y. (2006) · Frontiers in bioscience · doi:10.2741/1883 · Cited by 121

Structural Basis of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases

Maskos, K., & Bode, W. (2003) · Molecular Biotechnology · doi:10.1385/mb:25:3:241 · Cited by 120

Multilevel regulation of matrix metalloproteinases in tissue homeostasis indicates their molecular specificity in vivo

Gaffney, J. P., Solomonov, I., Zehorai, E., & Sagi, I. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.012 · Cited by 117

Attenuation of AD‐like neuropathology by harnessing peripheral immune cells: local elevation of IL‐10 and MMP‐9

Koronyo‐Hamaoui, M., Ko, M. K., Koronyo, Y., Azoulay, D., Seksenyan, A., Kunis, G., Pham, M. D., Bakhsheshian, J., Rogeri, P. S., Black, K. L., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06402.x · Cited by 116

Role of Amyloid Precursor Protein (APP) and Its Derivatives in the Biology and Cell Fate Specification of Neural Stem Cells

Coronel, R., Bernabeu-Zornoza, A., Palmer, C., Moreno, M. D. M. M., Zambrano, A., Cano, E., & Liste, I. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0914-2 · Cited by 112

Progress in the Development of Matrix Metalloproteinase Inhibitors

Tu, G.-G., Xu, W., Huang, H., & Li, S. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708784567680 · Cited by 112

Macrophage Matrix Metalloproteinase-12 Dampens Inflammation and Neutrophil Influx in Arthritis

Bellac, C. L., Dufour, A., Krisinger, M. J., Loonchanta, A., Starr, A. E., Keller, U. A. D., Lange, P. F., Goebeler, V., Kappelhoff, R., Butler, G. S., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.006 · Cited by 111

Metalloproteinases and their tissue inhibitors in Alzheimer’s disease and other neurodegenerative disorders.

Rivera, S., García-González, L., Khrestchatisky, M., & Baranger, K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03178-2 · Cited by 111

Matrix Metalloproteinase Inhibitors: New Challenges in the Era of Post Broad-Spectrum Inhibitors

Nuti, E., & Tuccinardi, T. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781039706 · Cited by 109

Targeting Matrix Metalloproteinases: Exploring the Dynamics of the S1′ Pocket in the Design of Selective, Small Molecule Inhibitors

Fabre, B., Ramos, A., & de Pascual‐Teresa, B. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500505f · Cited by 106

Membrane-type 5 matrix metalloproteinase is expressed in differentiated neurons and regulates axonal growth.

Hayashita‐Kinoh, H., Kinoh, H., Okada, A., Komori, K., Itoh, Y., Chiba, T., Kajita, M., Yana, I., & Seiki, M. (2001) · PubMed · Cited by 106

Membrane Localization of Membrane Type 5 Matrix Metalloproteinase by AMPA Receptor Binding Protein and Cleavage of Cadherins

Monea, S., Jordan, B. A., Srivastava, S., DeSouza, S., & Ziff, E. B. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3521-05.2006 · Cited by 104

Structural Bases for Substrate and Inhibitor Recognition by Matrix Metalloproteinases

Aureli, L., Gioia, M., Cerbara, I., Monaco, S., Fasciglione, G. F., Marini, S., Ascenzi, P., Topai, A., & Coletta, M. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785747490 · Cited by 101

New strategies for targeting matrix metalloproteinases.

Fields, G. B. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.002 · Cited by 98

Matrix metalloproteinase (MMP) system in brain: identification and characterization of brain-specific MMP highly expressed in cerebellum.

Sekine‐Aizawa, Y., Hama, E., Watanabe, K., Tsubuki, S., Kanai‐Azuma, M., Kanai, Y., Arai, H., Aizawa, H., Iwata, N., & Saido, T. C. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01462.x · Cited by 97

Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier

Tam, V. H., Sosa, C. L., Liu, R., Yao, N., & Priestley, R. D. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.031 · Cited by 97

Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease

Leake, A., Morris, C. M., & Whateley, J. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01418-x · Cited by 95

Cytoplasmic tail of MT1‐MMP regulates macrophage motility independently from its protease activity

Sakamoto, T., & Seiki, M. (2009) · Genes to Cells · doi:10.1111/j.1365-2443.2009.01293.x · Cited by 95

MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson’s Disease

Chung, Y. C., Kim, Y.-S., Bok, E., Yune, T. Y., Maeng, S., & Jin, B. K. (2013) · Mediators of Inflammation · doi:10.1155/2013/370526 · Cited by 94

Extracellular Matrix Proteolysis by MT1-MMP Contributes to Influenza-Related Tissue Damage and Mortality

Talmi-Frank, D., Altboum, Z., Solomonov, I., Udi, Y., Jaitin, D. A., Klepfish, M., David, E., Zhuravlev, A., Keren‐Shaul, H., Winter, D. R., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.09.005 · Cited by 94

Degradation of Soluble and Fibrillar Amyloid β-Protein by Matrix Metalloproteinase (MT1-MMP) in Vitro

Liao, M.-C., & Van Nostrand, W. E. (2010) · Biochemistry · doi:10.1021/bi901994d · Cited by 92

Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1′ cavity

Devel, L., Czarny, B., Beau, F., Georgiadis, D., Stura, E. A., & Dive, V. (2010) · Biochimie · doi:10.1016/j.biochi.2010.07.017 · Cited by 92

Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice

Fragkouli, A., Tsilibary, E. C., & Tzinia, A. K. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.06.021 · Cited by 90

Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-β stimulation via the PI3K/Akt pathway

Ito, S., Kimura, K., Haneda, M., Ishida, Y., Sawada, M., & Isobe, K. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2006.11.012 · Cited by 88

Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP

García-González, L., Pilat, D., Baranger, K., & Rivera, S. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00244 · Cited by 88

Small things matter: implications of APP intracellular domain AICD nuclear signaling in the progression and pathogenesis of Alzheimer’s disease.

Bukhari, H., Glotzbach, A., Kolbe, K., Leonhardt, G., Loosse, C., & Müller, T. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.05.005 · Cited by 88

Quinazolinones and Pyrido[3,4- d ]pyrimidin-4-ones as Orally Active and Specific Matrix Metalloproteinase-13 Inhibitors for the Treatment of Osteoarthritis

Li, J. J., Nahra, J., Johnson, A. R., Bunker, A. M., O’Brien, P., Yue, W.-S., Ortwine, D. F., Man, C.-F., Baragi, V., Kilgore, K. S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701274v · Cited by 88

Matrix metalloproteinase-9 involvement in the structural plasticity of dendritic spines

Stawarski, M., Stefaniuk, M., & Włodarczyk, J. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00068 · Cited by 87

Absence of mechanical allodynia and Aβ‐fiber sprouting after sciatic nerve injury in mice lacking membrane‐type 5 matrix metalloproteinase

Komori, K., Nonaka, T., Okada, A., Kinoh, H., Hayashita‐Kinoh, H., Yoshida, N., Yana, I., & Seiki, M. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01458-3 · Cited by 84

Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries

Nam, D. H., Rodríguez, C., Remacle, A. G., Strongin, A. Y., & Ge, X. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609375114 · Cited by 83

Cleavage of Amyloid-β Precursor Protein (APP) by Membrane-Type Matrix Metalloproteinases

Ahmad, M., Takino, T., Miyamori, H., Yoshizaki, T., Furukawa, M., & Sato, H. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj054 · Cited by 82

Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis

Kim, H. J., Fillmore, H. L., Reeves, T. M., & Phillips, L. L. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.10.014 · Cited by 81

Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulation

Folgueras, A. R., Valdés-Sánchez, T., Llano, E., Menéndez, L., Baamonde, A., Denlinger, B. L., Belmonte, C., Juárez, L., Lastra, A., García-Suárez, O., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908507106 · Cited by 80

Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells

Izidoro‐Toledo, T. C., Guimarães, D. A., Belo, V. D. A., Gerlach, R. F., & Tanus-Santos, J. E. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0623-0 · Cited by 79

C-terminal truncation of IFN-γ inhibits proinflammatory macrophage responses and is deficient in autoimmune disease

Dufour, A., Bellac, C., Eckhard, U., Solis, N., Klein, T., Kappelhoff, R., Fortelny, N., Jobin, P., Rozmus, J., Mark, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04717-4 · Cited by 79

Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer’s disease: evidence for a pro-amyloidogenic role of MT1-MMP

Py, N. A., Bonnet, A. E., Bernard, A., Marchalant, Y., Charrat, E., Checler, F., Khrestchatisky, M., Baranger, K., & Rivera, S. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00247 · Cited by 76

X-ray Absorption Studies of Human Matrix Metalloproteinase-2 (MMP-2) Bound to a Highly Selective Mechanism-based Inhibitor

Kleifeld, O., Kotra, L. P., Gervasi, D. C., Brown, S., Bernardo, M. M., Fridman, R. A., Mobashery, S., & Sagi, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011604200 · Cited by 73

Design and Structural Evolution of Matrix Metalloproteinase Inhibitors

Fischer, T., Senn, N., & Riedl, R. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201805361 · Cited by 73

Cartilage degradation biomarkers predict efficacy of a novel, highly selective matrix metalloproteinase 13 inhibitor in a dog model of osteoarthritis: Confirmation by multivariate analysis that modulation of type ii collagen and aggrecan degradation peptides parallels pathologic changes

Settle, S. L., Vickery, L. E., Nemirovskiy, O. V., Vidmar, T. J., Bendele, A. M., Messing, D., Ruminski, P., Schnute, M. E., & Sunyer, T. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27596 · Cited by 72

Synaptic Autoregulation by Metalloproteases and γ-Secretase

Restituito, S., Khatri, L., Ninan, I., Mathews, P. M., Liu, X., Weinberg, R. J., & Ziff, E. B. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2513-11.2011 · Cited by 70

Structural Basis for Matrix Metalloproteinase-2 (MMP-2)-selective Inhibitory Action of β-Amyloid Precursor Protein-derived Inhibitor

Hashimoto, H., Takeuchi, T., Komatsu, K., Miyazaki, K., Sato, M., & Higashi, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.264176 · Cited by 69

MT5-MMP, ADAM-10, and N-Cadherin Act in Concert To Facilitate Synapse Reorganization after Traumatic Brain Injury

Harrell, K. M., Reeves, T. M., & Phillips, L. L. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2012.2383 · Cited by 69

Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies

Nuti, E., Cuffaro, D., Bernardini, E., Camodeca, C., Panelli, L., Chaves, S., Ciccone, L., Tepshi, L., Vera, L., Orlandini, E., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00096 · Cited by 69

Matrix metalloproteinases and ADAMs in stroke

Montaner, J., Ramiro, L., Simats, A., Hernández‐Guillamón, M., Delgado, P., Bustamante, A., & Rosell, A. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03175-5 · Cited by 67

Sulphonamides: Deserving class as MMP inhibitors?

Jain, P., Saravanan, C., & Singh, S. K. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.10.016 · Cited by 66

MMPs and ADAMs in neurological infectious diseases and multiple sclerosis

Muri, L., Leppert, D., Grandgirard, D., & Leib, S. L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03174-6 · Cited by 65

Identification of a Region of β-Amyloid Precursor Protein Essential for Its Gelatinase A Inhibitory Activity

Higashi, S., & Miyazaki, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212264200 · Cited by 65

Recent Research Advances in Selective Matrix Metalloproteinase‐13 Inhibitors as Anti‐Osteoarthritis Agents

Xie, X., Wan, R., & Liu, Z. (2017) · ChemMedChem · doi:10.1002/cmdc.201700349 · Cited by 65

Unraveling Hidden Regulatory Sites in Structurally Homologous Metalloproteases

Udi, Y., Fragai, M., Grossman, M., Mitternacht, S., Arad‐Yellin, R., Calderone, V., Melikian, M., Toccafondi, M., Berezovsky, I. N., Luchinat, C., et al. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.04.009 · Cited by 64

The emerging role of MMP14 in brain tumorigenesis and future therapeutics

Ulasov, I. V., Yi, R., Guo, D., Sarvaiya, P. J., & Cobbs, C. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.03.002 · Cited by 64

Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach

Nara, H., Sato, K., Naito, T., Mototani, H., Oki, H., Yamamoto, Y., Kuno, H., Santou, T., Kanzaki, N., Terauchi, J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500981k · Cited by 63

Regulation of matrix metalloproteinase 2 by oligomeric amyloid β protein

Li, W., Poteet, E. C., Xie, L., Liu, R., Wen, Y., & Yang, S.-H. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.078 · Cited by 61

Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach

Nara, H., Kaieda, A., Sato, K., Naito, T., Mototani, H., Oki, H., Yamamoto, Y., Kuno, H., Santou, T., Kanzaki, N., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01007 · Cited by 61

Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches

Kumar, N. N., Pizzo, M. E., Nehra, G., Wilken-Resman, B., Boroumand, S., & Thorne, R. G. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00548 · Cited by 60

Inhibition Mechanism of Membrane Metalloprotease by an Exosite-Swiveling Conformational Antibody

Udi, Y., Grossman, M., Solomonov, I., Dym, O., Rozenberg, H., Moreno, V., Cuniasse, P., Dive, V., Arroyo, A. G., & Sagi, I. (2014) · Structure · doi:10.1016/j.str.2014.10.012 · Cited by 60

Developmental regulation of membrane type-5 matrix metalloproteinase (MT5-MMP) expression in the rat nervous system

Jaworski, D. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02035-7 · Cited by 59

High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate

Lauer‐Fields, J. L., Minond, D., Chase, P. S., Baillargeon, P., Saldanha, S. A., Stawikowska, R., Hodder, P., & Fields, G. B. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.03.004 · Cited by 59

Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence

Wilcock, D. M., Morgan, D., Gordon, M. N., Taylor, T. L., Ridnour, L. A., Wink, D. A., & Colton, C. A. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-115 · Cited by 58

Impact of Matrix Metalloproteinases on Atherosclerosis

Lin, J., Kakkar, V. V., & Lu, X. (2014) · Current Drug Targets · doi:10.2174/1389450115666140211115805 · Cited by 57

Matrix metalloproteinase-13 participates in neuroprotection and neurorepair after cerebral ischemia in mice

Ma, F., Segundo, P. M. S., Barceló, V., Morancho, A., Gabriel-Salazar, M., Giralt, D., Montaner, J., & Rosell, A. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.03.016 · Cited by 56

Matrix metalloproteinases in the CNS: interferons get nervous

Chopra, S., Overall, C. M., & Dufour, A. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03171-9 · Cited by 56

Insights from Selective Non-phosphinic Inhibitors of MMP-12 Tailored to Fit with an S1′ Loop Canonical Conformation

Devel, L., Garcia, S., Czarny, B., Beau, F., Lajeunesse, E. C., Vera, L., Georgiadis, D., Stura, E. A., & Dive, V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139634 · Cited by 55

Role of Matrix Metalloproteinases in Migration and Neurotrophic Properties of Nasal Olfactory Stem and Ensheathing Cells

Ould‐Yahoui, A., Sbai, O., Baranger, K., Bernard, A., Gueye, Y., Charrat, E., Clément, B., Gigmès, D., Dive, V., Girard, S. D., et al. (2013) · Cell Transplantation · doi:10.3727/096368912x657468 · Cited by 54

Matrix metalloproteinase protein inhibitors: highlighting a new beginning for metalloproteinases in medicine

Sagi, I., Talmi-Frank, D., Arkadash, V., Papo, N., & Mohan, V. (2016) · Metalloproteinases In Medicine · doi:10.2147/mnm.s65143 · Cited by 54

MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation

Zhu, B., Long, Y., Luo, W., Yan, Z., Lai, Y., Zhao, L., Zhou, W., Wang, Y., Shen, L., Liu, L., et al. (2018) · Brain · doi:10.1093/brain/awy305 · Cited by 53

Novel Processing of β-Amyloid Precursor Protein Catalyzed by Membrane Type 1 Matrix Metalloproteinase Releases a Fragment Lacking the Inhibitor Domain against Gelatinase A

Higashi, S., & Miyazaki, K. (2003) · Biochemistry · doi:10.1021/bi020643m · Cited by 53

Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors

Choi, J. Y., Fuerst, R., Knapinska, A. M., Taylor, A. B., Smith, L., Cao, X., Hart, P. J., Fields, G., & Roush, W. R. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00514 · Cited by 53

Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade

Kaneko, K., Williams, R. O., Dransfield, D. T., Nixon, A. E., Sandison, A., & Itoh, Y. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39414 · Cited by 53

Endogenous and synthetic MMP inhibitors in CNS physiopathology.

Baranger, K., Rivera, S., Liechti, F. D., Grandgirard, D., Bigas, J., Seco, J., Tarrago, T., Leib, S. L., & Khrestchatisky, M. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63486-3.00014-1 · Cited by 52

Integrated functions of membrane‐type 1 matrix metalloproteinase in regulating cancer malignancy: Beyond a proteinase

Sakamoto, T., & Seiki, M. (2017) · Cancer Science · doi:10.1111/cas.13231 · Cited by 51

Functional selection of protease inhibitory antibodies

Lopez, T., Mustafa, Z., Chen, C., Lee, K. B., Ramirez, A., Benitez, C., Luo, X., Ji, R., & Ge, X. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903330116 · Cited by 51

Sugar‐Based Arylsulfonamide Carboxylates as Selective and Water‐Soluble Matrix Metalloproteinase‐12 Inhibitors

Nuti, E., Cuffaro, D., D’Andrea, F., Rosalia, L., Tepshi, L., Fabbi, M., Carbotti, G., Ferrini, S., Santamaria, S., Camodeca, C., et al. (2016) · ChemMedChem · doi:10.1002/cmdc.201600235 · Cited by 51

Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain

Liu, Y., Zhang, M., Hao, W., Mihaljevic, I., Liu, X., Xie, K., Walter, S., & Fassbender, K. C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.015 · Cited by 50

MMP-9 Inhibitor SB-3CT Attenuates Behavioral Impairments and Hippocampal Loss after Traumatic Brain Injury in Rat

Jia, F., Yin, Y.-H., Gao, G.-Y., Wang, Y., Cen, L., & Jiang, J.-Y. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3230 · Cited by 49

Molecular Determinants of a Selective Matrix Metalloprotease-12 Inhibitor: Insights from Crystallography and Thermodynamic Studies

Czarny, B., Stura, E. A., Devel, L., Vera, L., Lajeunesse, E. C., Beau, F., Calderone, V., Fragai, M., Luchinat, C., & Dive, V. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301574d · Cited by 48

Membrane‐type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases

Langenfurth, A., Rinnenthal, J. L., Vinnakota, K., Prinz, V., Carlo, A.-S., Stadelmann, C., Siffrin, V., Peaschke, S., Endres, M., Heppner, F. L., et al. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23288 · Cited by 47

Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions

Alford, V. M., Kamath, A., Ren, X., Kumar, K., Gan, Q., Awwa, M., Tong, M., Seeliger, M. A., Cao, J. P., Ojima, I., et al. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00758 · Cited by 47

Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology

Ashry, E. S. H. E., Awad, L. F., Teleb, M., Ibrahim, N. A., Abu-Serie, M. M., & Moaty, M. N. A. A. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103616 · Cited by 47

Multifunctional Hybrid Sulfonamides as Novel Therapeutic Agents for Alzheimer’s Disease

Swetha, R., Kumar, D., Gupta, S. K., Ganeshpurkar, A., Singh, R., Gutti, G., Kumar, D., Jana, S., Krishnamurthy, S., & Singh, S. K. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0106 · Cited by 46

Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer’s Disease-Related Pathology

Terni, B., & Ferrer, I. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142460 · Cited by 46

Trafficking and secretion of matrix metalloproteinase‐2 in olfactory ensheathing glial cells: A role in cell migration?

Gueye, Y., Ferhat, L., Sbai, O., Bianco, J. I., Ould‐Yahoui, A., Bernard, A., Charrat, E., Chauvin, J., Risso, J., Feron, F. P., et al. (2011) · Glia · doi:10.1002/glia.21146 · Cited by 46

Monoclonal antibodies against metzincin targets

Santamaria, S., & de Groot, R. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14186 · Cited by 45

Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis

Remacle, A. G., Cieplak, P., Nam, D. H., Shiryaev, S. A., Ge, X., & Strongin, A. Y. (2016) · Oncotarget · doi:10.18632/oncotarget.13157 · Cited by 45

Zinc–Metalloproteinase Inhibitors: Evaluation of the Complex Role Played by the Zinc-Binding Group on Potency and Selectivity

Rouanet-Mehouas, C., Czarny, B., Beau, F., Lajeunesse, E. C., Stura, E. A., Dive, V., & Devel, L. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01420 · Cited by 45

MT5-MMP Promotes Alzheimer’s Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in vitro

Baranger, K., Bonnet, A. E., Girard, S. D., Paumier, J.-M., García-González, L., Elmanaa, W., Bernard, A., Charrat, E., Stephan, D., Bauer, C., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00163 · Cited by 44

Regional and age-related expression of gelatinases in the brains of young and old rats after treatment with kainic acid

Zhang, J. W., Deb, S., & Gottschall, P. E. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01582-2 · Cited by 42

Simple Pseudo-dipeptides with a P2′ Glutamate

Devel, L., Beau, F., Amoura, M., Vera, L., Lajeunesse, E. C., Garcia, S., Czarny, B., Stura, E. A., & Dive, V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.380782 · Cited by 42

Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo

Bøtkjær, K. A., Kwok, H. F., Terp, M. G., Karatt-Vellatt, A., Santamaria, S., McCafferty, J., Andreasen, P. A., Itoh, Y., Ditzel, H. J., & Murphy, G. (2016) · Oncotarget · doi:10.18632/oncotarget.7780 · Cited by 41

Matrix Metalloproteinase-12 Deficiency Worsens Relapsing-Remitting Experimental Autoimmune Encephalomyelitis in Association with Cytokine and Chemokine Dysregulation

DaSilva, A. G., & Yong, V. W. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080952 · Cited by 41

Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking.

Paumier, J.-M., Py, N. A., García-González, L., Bernard, A., Stephan, D., Louis, L., Checler, F., Khrestchatisky, M., Baranger, K., & Rivera, S. (2019) · The FASEB Journal · doi:10.1096/fj.201801076r · Cited by 40

Inhibition of matrix metalloproteinases-2 and -9 prevents cognitive impairment induced by pneumococcal meningitis in Wistar rats

Barichello, T., Generoso, J. S., Michelon, C. M., Simões, L. R., Galvão-Elias, S., Vuolo, F., Comim, C. M., Dal‐Pizzol, F., & Quevedo, J. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370213508354 · Cited by 39

Recent insights into natural product inhibitors of matrix metalloproteinases

Kumar, G. B., Nair, B. G., Perry, J. J. P., & Martin, D. B. C. (2019) · MedChemComm · doi:10.1039/c9md00165d · Cited by 39

Selective Gelatinase Inhibitor Neuroprotective Agents Cross the Blood-Brain Barrier

Gooyit, M., Suckow, M. A., Schroeder, V. A., Wolter, W. R., Mobashery, S., & Chang, M. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300062w · Cited by 37

Matrix metalloproteinase-14 triggers an anti-inflammatory proteolytic cascade in endotoxemia

Aguirre, A., Blázquez-Prieto, J., Amado‐Rodríguez, L., López-Alonso, I., Batalla-Solís, E., González-López, A., Sánchez-Pérez, M., Mayoral-García, C., Gutiérrez‐Fernández, A., & Albaiceta, G. M. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1510-z · Cited by 37

O-Phenyl Carbamate and Phenyl Urea Thiiranes as Selective Matrix Metalloproteinase-2 Inhibitors that Cross the Blood–Brain Barrier

Gooyit, M., Song, W., Mahasenan, K. V., Lichtenwalter, K., Suckow, M. A., Schroeder, V. A., Wolter, W. R., Mobashery, S., & Chang, M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401217d · Cited by 36

Molecular Design of a Highly Selective and Strong Protein Inhibitor against Matrix Metalloproteinase-2 (MMP-2)

Higashi, S., Hirose, T., Takeuchi, T., & Miyazaki, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.441758 · Cited by 36

Matrix metalloproteinase-9 regulates neuronal circuit development and excitability

Murase, S., Lantz, C. L., Kim, E., Gupta, N., Higgins, R., Stopfer, M., Hoffman, D. A., & Quinlan, E. M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9295-y · Cited by 35

Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives

Behl, T., Kaur, G., Sehgal, A., Bhardwaj, S., Singh, S., Buhaș, C. L., Pusta, C. T. J., Uivaroșan, D., Munteanu, M. A., & BUNGAU, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031413 · Cited by 198

The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer

He, L., Kang, Q., Chan, K. I., Zhang, Y., Zhong, Z., & Tan, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1093990 · Cited by 151

Microglial activation states and their implications for Alzheimer's Disease

Valiukas, Z., Tangalakis, K., Apostolopoulos, V., & Feehan, J. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2024.100013 · Cited by 167

Protein Misfolding and Aggregation in Proteinopathies: Causes, Mechanism and Cellular Response

Ajmal, M. R. (2023) · Diseases · doi:10.3390/diseases11010030 · Cited by 116

Collagen in the central nervous system: contributions to neurodegeneration and promise as a therapeutic target

Wareham, L. K., Baratta, R. O., Buono, B. J. D., Schlumpf, E., & Calkins, D. J. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00704-0 · Cited by 111

Current Insights on CNS-Targeted Matrix Metalloproteinase Inhibitors for the Management of Alzheimer’s Disease

Kumar, S., Kumari, J., Kommi, D. N., & Khatik, G. L. (2026) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249471785260829144035

The Potential Use of Matrix Metalloproteinases in Alzheimer’s Disease Therapy

Krawczuk, D., & Mroczko, B. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15041555 · Cited by 3

Matrix Metalloproteinases as Therapeutic Targets of Neuroinflammation in Alzheimer’s Disease

Li, S. (2025) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2025.63.009903

The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology

Radošinská, D., & Radošinská, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04315-0 · Cited by 50

Matrix Metalloproteinases and Their Multiple Roles in Alzheimer's Disease

Wang, X.-X., Tan, M.-S., Yu, J.-T., & Tan, L. (2014) · BioMed Research International · doi:10.1155/2014/908636 · Cited by 55